Home Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
 

Keywords :   


Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis

2013-11-04 12:23:21| Biotech - Topix.net

Active Biotech announced today that its partner Teva Pharmaceutical Industries Ltd. will initiate a further clinical trial, LIBRETTO, to evaluate the efficacy, safety and tolerability of two doses of oral laquinimod , compared to interferon beta-1a, in patients with relapsing remitting multiple sclerosis.

Tags: partner active multiple trial

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11CERM launches new MIS products, Mark Andy innovates and more
01.11Removing a major trade barrier: Full access to Colombia restored for U.S. beef
01.11Global BEEF Series: Leveling the playing field on quality beef
01.11Getting more out of fall and winter grazing
01.11U.S. Boston butt burger launches in Colombia
01.11All Americans have a role in keeping African swine fever out
More »